Brief: Foghorn Therapeutics Q3 EPS USD -0.25
Nov 05 (Reuters) - Foghorn Therapeutics Q3 collaboration revenue USD 8.153 million. Q3 net income USD -15.849 million
Nov 05 (Reuters) - Foghorn Therapeutics Q3 collaboration revenue USD 8.153 million. Q3 net income USD -15.849 million